Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash to Debt 0.22
ABC's Cash to Debt is ranked lower than
80% of the 46 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.66 vs. ABC: 0.22 )
Ranked among companies with meaningful Cash to Debt only.
ABC' s Cash to Debt Range Over the Past 10 Years
Min: 0.06  Med: 0.48 Max: 1.7
Current: 0.22
0.06
1.7
Equity to Asset 0.04
ABC's Equity to Asset is ranked lower than
96% of the 45 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.40 vs. ABC: 0.04 )
Ranked among companies with meaningful Equity to Asset only.
ABC' s Equity to Asset Range Over the Past 10 Years
Min: -0.1  Med: 0.20 Max: 0.38
Current: 0.04
-0.1
0.38
Interest Coverage 3.53
ABC's Interest Coverage is ranked lower than
78% of the 36 Companies
in the Global Medical Distribution industry.

( Industry Median: 8.25 vs. ABC: 3.53 )
Ranked among companies with meaningful Interest Coverage only.
ABC' s Interest Coverage Range Over the Past 10 Years
Min: 4.09  Med: 14.42 Max: N/A
Current: 3.53
F-Score: 5
Z-Score: 4.83
M-Score: -2.54
WACC vs ROIC
7.34%
15.71%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 6/10

vs
industry
vs
history
Operating margin (%) 0.23
ABC's Operating margin (%) is ranked lower than
87% of the 46 Companies
in the Global Medical Distribution industry.

( Industry Median: 4.25 vs. ABC: 0.23 )
Ranked among companies with meaningful Operating margin (%) only.
ABC' s Operating margin (%) Range Over the Past 10 Years
Min: 0.31  Med: 1.23 Max: 1.67
Current: 0.23
0.31
1.67
Net-margin (%) 0.28
ABC's Net-margin (%) is ranked lower than
83% of the 46 Companies
in the Global Medical Distribution industry.

( Industry Median: 2.50 vs. ABC: 0.28 )
Ranked among companies with meaningful Net-margin (%) only.
ABC' s Net-margin (%) Range Over the Past 10 Years
Min: -0.1  Med: 0.71 Max: 0.92
Current: 0.28
-0.1
0.92
ROE (%) 27.48
ABC's ROE (%) is ranked higher than
96% of the 45 Companies
in the Global Medical Distribution industry.

( Industry Median: 10.00 vs. ABC: 27.48 )
Ranked among companies with meaningful ROE (%) only.
ABC' s ROE (%) Range Over the Past 10 Years
Min: -10.41  Med: 15.57 Max: 27.02
Current: 27.48
-10.41
27.02
ROA (%) 1.44
ABC's ROA (%) is ranked lower than
78% of the 45 Companies
in the Global Medical Distribution industry.

( Industry Median: 3.50 vs. ABC: 1.44 )
Ranked among companies with meaningful ROA (%) only.
ABC' s ROA (%) Range Over the Past 10 Years
Min: -0.55  Med: 3.81 Max: 4.8
Current: 1.44
-0.55
4.8
ROC (Joel Greenblatt) (%) 30.60
ABC's ROC (Joel Greenblatt) (%) is ranked higher than
67% of the 45 Companies
in the Global Medical Distribution industry.

( Industry Median: 22.89 vs. ABC: 30.60 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
ABC' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years
Min: 40.04  Med: 130.02 Max: 184.88
Current: 30.6
40.04
184.88
Revenue Growth (3Y)(%) 27.10
ABC's Revenue Growth (3Y)(%) is ranked higher than
92% of the 37 Companies
in the Global Medical Distribution industry.

( Industry Median: 5.60 vs. ABC: 27.10 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
ABC' s Revenue Growth (3Y)(%) Range Over the Past 10 Years
Min: 7.9  Med: 15.60 Max: 28.5
Current: 27.1
7.9
28.5
EBITDA Growth (3Y)(%) -20.20
ABC's EBITDA Growth (3Y)(%) is ranked lower than
89% of the 35 Companies
in the Global Medical Distribution industry.

( Industry Median: 8.30 vs. ABC: -20.20 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
ABC' s EBITDA Growth (3Y)(%) Range Over the Past 10 Years
Min: -20.2  Med: 15.20 Max: 26.9
Current: -20.2
-20.2
26.9
» ABC's 10-Y Financials

Financials (Next Earnings Date: 2016-05-05)


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q2 2015

ABC Guru Trades in Q2 2015

Joel Greenblatt 18,921 sh (New)
Jim Simons 1,085,300 sh (New)
Pioneer Investments 40,076 sh (+425.04%)
Paul Tudor Jones 5,900 sh (+68.57%)
Jeremy Grantham 75,800 sh (-0.92%)
Ken Fisher 120,404 sh (-9.22%)
John Keeley 58,051 sh (-17.40%)
Ray Dalio 42,343 sh (-38.31%)
» More
Q3 2015

ABC Guru Trades in Q3 2015

Ray Dalio 47,443 sh (+12.04%)
Pioneer Investments Sold Out
Joel Greenblatt Sold Out
John Keeley 57,281 sh (-1.33%)
Ken Fisher 118,152 sh (-1.87%)
Jim Simons 781,200 sh (-28.02%)
Paul Tudor Jones 4,100 sh (-30.51%)
Jeremy Grantham 42,950 sh (-43.34%)
» More
Q4 2015

ABC Guru Trades in Q4 2015

George Soros 3,900 sh (New)
Jim Simons 1,410,100 sh (+80.50%)
Ray Dalio 58,485 sh (+23.27%)
Ken Fisher 112,848 sh (-4.49%)
Paul Tudor Jones 2,200 sh (-46.34%)
John Keeley 29,021 sh (-49.34%)
Jeremy Grantham 10,700 sh (-75.09%)
» More
Q1 2016

ABC Guru Trades in Q1 2016

Ken Fisher 110,647 sh (-1.95%)
» More
» Details

Insider Trades

Latest Guru Trades with ABC

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Top Ranked Articles about AmerisourceBergen Corp

A Short-Term Problem Creates Long-Term Opportunity in Lannett Company Generic drug manufacturer is mispriced due to irrational fears
I use several different techniques to search for potential investment opportunities. But, there is no question that I strongly favor value investing because I like large margins of safety surrounding my money. Read more...

Ratios

vs
industry
vs
history
P/E(ttm) 48.40
ABC's P/E(ttm) is ranked lower than
85% of the 40 Companies
in the Global Medical Distribution industry.

( Industry Median: 22.00 vs. ABC: 48.40 )
Ranked among companies with meaningful P/E(ttm) only.
ABC' s P/E(ttm) Range Over the Past 10 Years
Min: 11.12  Med: 19.40 Max: 1317.44
Current: 48.4
11.12
1317.44
Forward P/E 13.05
ABC's Forward P/E is ranked higher than
58% of the 12 Companies
in the Global Medical Distribution industry.

( Industry Median: 15.87 vs. ABC: 13.05 )
Ranked among companies with meaningful Forward P/E only.
N/A
PE(NRI) 48.40
ABC's PE(NRI) is ranked lower than
85% of the 40 Companies
in the Global Medical Distribution industry.

( Industry Median: 22.00 vs. ABC: 48.40 )
Ranked among companies with meaningful PE(NRI) only.
ABC' s PE(NRI) Range Over the Past 10 Years
Min: 9.93  Med: 17.06 Max: 1284.5
Current: 48.4
9.93
1284.5
Price/Owner Earnings (ttm) 6.20
ABC's Price/Owner Earnings (ttm) is ranked higher than
88% of the 25 Companies
in the Global Medical Distribution industry.

( Industry Median: 23.85 vs. ABC: 6.20 )
Ranked among companies with meaningful Price/Owner Earnings (ttm) only.
ABC' s Price/Owner Earnings (ttm) Range Over the Past 10 Years
Min: 5.09  Med: 11.32 Max: 228.96
Current: 6.2
5.09
228.96
P/B 13.39
ABC's P/B is ranked lower than
98% of the 44 Companies
in the Global Medical Distribution industry.

( Industry Median: 2.19 vs. ABC: 13.39 )
Ranked among companies with meaningful P/B only.
ABC' s P/B Range Over the Past 10 Years
Min: 1.55  Med: 3.08 Max: 34.65
Current: 13.39
1.55
34.65
P/S 0.14
ABC's P/S is ranked higher than
89% of the 44 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.10 vs. ABC: 0.14 )
Ranked among companies with meaningful P/S only.
ABC' s P/S Range Over the Past 10 Years
Min: 0.07  Med: 0.14 Max: 0.2
Current: 0.14
0.07
0.2
PFCF 5.42
ABC's PFCF is ranked higher than
95% of the 19 Companies
in the Global Medical Distribution industry.

( Industry Median: 19.63 vs. ABC: 5.42 )
Ranked among companies with meaningful PFCF only.
ABC' s PFCF Range Over the Past 10 Years
Min: 5.42  Med: 9.97 Max: 50.52
Current: 5.42
5.42
50.52
POCF 5.02
ABC's POCF is ranked higher than
92% of the 25 Companies
in the Global Medical Distribution industry.

( Industry Median: 16.16 vs. ABC: 5.02 )
Ranked among companies with meaningful POCF only.
ABC' s POCF Range Over the Past 10 Years
Min: 4.91  Med: 8.66 Max: 463.25
Current: 5.02
4.91
463.25
EV-to-EBIT 70.06
ABC's EV-to-EBIT is ranked lower than
100% of the 38 Companies
in the Global Medical Distribution industry.

( Industry Median: 16.35 vs. ABC: 70.06 )
Ranked among companies with meaningful EV-to-EBIT only.
ABC' s EV-to-EBIT Range Over the Past 10 Years
Min: -161.6  Med: 9.80 Max: 323.4
Current: 70.06
-161.6
323.4
EV-to-EBITDA 35.70
ABC's EV-to-EBITDA is ranked lower than
87% of the 39 Companies
in the Global Medical Distribution industry.

( Industry Median: 11.91 vs. ABC: 35.70 )
Ranked among companies with meaningful EV-to-EBITDA only.
ABC' s EV-to-EBITDA Range Over the Past 10 Years
Min: 5.9  Med: 9.00 Max: 662.8
Current: 35.7
5.9
662.8
Shiller P/E 49.38
ABC's Shiller P/E is ranked lower than
82% of the 17 Companies
in the Global Medical Distribution industry.

( Industry Median: 29.60 vs. ABC: 49.38 )
Ranked among companies with meaningful Shiller P/E only.
ABC' s Shiller P/E Range Over the Past 10 Years
Min: 16.19  Med: 28.86 Max: 84.91
Current: 49.38
16.19
84.91
Current Ratio 0.85
ABC's Current Ratio is ranked lower than
93% of the 43 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.64 vs. ABC: 0.85 )
Ranked among companies with meaningful Current Ratio only.
ABC' s Current Ratio Range Over the Past 10 Years
Min: 0.85  Med: 1.27 Max: 1.74
Current: 0.85
0.85
1.74
Quick Ratio 0.40
ABC's Quick Ratio is ranked lower than
98% of the 43 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.12 vs. ABC: 0.40 )
Ranked among companies with meaningful Quick Ratio only.
ABC' s Quick Ratio Range Over the Past 10 Years
Min: 0.37  Med: 0.52 Max: 0.68
Current: 0.4
0.37
0.68
Days Inventory 27.19
ABC's Days Inventory is ranked higher than
80% of the 44 Companies
in the Global Medical Distribution industry.

( Industry Median: 49.82 vs. ABC: 27.19 )
Ranked among companies with meaningful Days Inventory only.
ABC' s Days Inventory Range Over the Past 10 Years
Min: 22.26  Med: 24.94 Max: 26.6
Current: 27.19
22.26
26.6
Days Sales Outstanding 21.99
ABC's Days Sales Outstanding is ranked higher than
90% of the 39 Companies
in the Global Medical Distribution industry.

( Industry Median: 57.83 vs. ABC: 21.99 )
Ranked among companies with meaningful Days Sales Outstanding only.
ABC' s Days Sales Outstanding Range Over the Past 10 Years
Min: 17.6  Med: 19.23 Max: 25.11
Current: 21.99
17.6
25.11
Days Payable 60.78
ABC's Days Payable is ranked lower than
54% of the 39 Companies
in the Global Medical Distribution industry.

( Industry Median: 62.84 vs. ABC: 60.78 )
Ranked among companies with meaningful Days Payable only.
ABC' s Days Payable Range Over the Past 10 Years
Min: 39.24  Med: 44.32 Max: 57.57
Current: 60.78
39.24
57.57

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 1.47
ABC's Dividend Yield is ranked lower than
57% of the 44 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.91 vs. ABC: 1.47 )
Ranked among companies with meaningful Dividend Yield only.
ABC' s Dividend Yield Range Over the Past 10 Years
Min: 0.11  Med: 0.98 Max: 1.47
Current: 1.47
0.11
1.47
Dividend Payout 0.67
ABC's Dividend Payout is ranked lower than
91% of the 34 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.33 vs. ABC: 0.67 )
Ranked among companies with meaningful Dividend Payout only.
ABC' s Dividend Payout Range Over the Past 10 Years
Min: 0.02  Med: 0.11 Max: 1.12
Current: 0.67
0.02
1.12
Dividend Growth (3y) 30.70
ABC's Dividend Growth (3y) is ranked higher than
87% of the 24 Companies
in the Global Medical Distribution industry.

( Industry Median: 11.50 vs. ABC: 30.70 )
Ranked among companies with meaningful Dividend Growth (3y) only.
ABC' s Dividend Growth (3y) Range Over the Past 10 Years
Min: 0  Med: 29.80 Max: 81.7
Current: 30.7
0
81.7
Forward Dividend Yield 1.59
ABC's Forward Dividend Yield is ranked lower than
57% of the 46 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.97 vs. ABC: 1.59 )
Ranked among companies with meaningful Forward Dividend Yield only.
N/A
Yield on cost (5-Year) 5.52
ABC's Yield on cost (5-Year) is ranked higher than
75% of the 52 Companies
in the Global Medical Distribution industry.

( Industry Median: 3.70 vs. ABC: 5.52 )
Ranked among companies with meaningful Yield on cost (5-Year) only.
ABC' s Yield on cost (5-Year) Range Over the Past 10 Years
Min: 0.41  Med: 3.68 Max: 5.52
Current: 5.52
0.41
5.52
3-Year Average Share Buyback Ratio 5.40
ABC's 3-Year Average Share Buyback Ratio is ranked higher than
97% of the 32 Companies
in the Global Medical Distribution industry.

( Industry Median: -0.80 vs. ABC: 5.40 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
ABC' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -30.6  Med: 5.10 Max: 10
Current: 5.4
-30.6
10

Valuation & Return

vs
industry
vs
history
Price/Projected FCF 0.79
ABC's Price/Projected FCF is ranked higher than
88% of the 26 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.36 vs. ABC: 0.79 )
Ranked among companies with meaningful Price/Projected FCF only.
ABC' s Price/Projected FCF Range Over the Past 10 Years
Min: 0.32  Med: 0.81 Max: 8.94
Current: 0.79
0.32
8.94
Price/Median PS Value 0.98
ABC's Price/Median PS Value is ranked higher than
63% of the 38 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.03 vs. ABC: 0.98 )
Ranked among companies with meaningful Price/Median PS Value only.
ABC' s Price/Median PS Value Range Over the Past 10 Years
Min: 0.5  Med: 1.04 Max: 1.81
Current: 0.98
0.5
1.81
Price/Graham Number 4.34
ABC's Price/Graham Number is ranked lower than
99.99% of the 29 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.66 vs. ABC: 4.34 )
Ranked among companies with meaningful Price/Graham Number only.
ABC' s Price/Graham Number Range Over the Past 10 Years
Min: 1.31  Med: 3.16 Max: 23.86
Current: 4.34
1.31
23.86
Earnings Yield (Greenblatt) (%) 1.39
ABC's Earnings Yield (Greenblatt) (%) is ranked lower than
88% of the 43 Companies
in the Global Medical Distribution industry.

( Industry Median: 5.70 vs. ABC: 1.39 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
ABC' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: 0.3  Med: 10.00 Max: 15
Current: 1.39
0.3
15
Forward Rate of Return (Yacktman) (%) -17.13
ABC's Forward Rate of Return (Yacktman) (%) is ranked lower than
97% of the 30 Companies
in the Global Medical Distribution industry.

( Industry Median: 10.84 vs. ABC: -17.13 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
ABC' s Forward Rate of Return (Yacktman) (%) Range Over the Past 10 Years
Min: -19.3  Med: 19.20 Max: 29.5
Current: -17.13
-19.3
29.5

More Statistics

Revenue(Mil) $139082
EPS $ 1.74
Beta0.89
Short Percentage of Float5.77%
52-Week Range $80.50 - 116.28
Shares Outstanding(Mil)205.46

Analyst Estimate

Sep16 Sep17 Sep18
Revenue(Mil) 147,918 160,359 173,760
EPS($) 5.79 6.55 7.71
EPS without NRI($) 5.79 6.55 7.71

Business Description

Industry: Medical Distribution » Medical Distribution
Compare:NYSE:MCK, NYSE:CAH, NAS:HSIC, HKSE:01099, SHSE:601607 » details
Traded in other countries:ABG.Germany,
AmerisourceBergen Corp was incorporated in Delaware in 2001. It is a pharmaceutical sourcing and distribution services company. It serves healthcare providers and pharmaceutical manufacturers in the pharmaceutical supply channel and provides drug distribution and related services designed to reduce costs and improve patient outcomes. The Company distributes a comprehensive offering of brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a variety of healthcare providers mainly located in the United States and Canada, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical and dialysis clinics, physicians, long-term care and other alternate site pharmacies and other customers. It also provides pharmacy services to certain specialty drug patients. Additionally, it furnishes healthcare providers and pharmaceutical manufacturers with an assortment of related services including pharmaceutical packaging, pharmacy automation, inventory management, reimbursement and pharmaceutical consulting services, logistics services, and pharmacy management. It operates in United States and Canada. It currently serves its customers through a geographically diverse network of distribution service centers and other operations in the United States and Canada, and through packaging facilities in the United States and the United Kingdom. The Company's national competitors are Cardinal Health, Inc. and McKesson Corporation. It is subject to oversight by various federal and state governmental entities and it is subject to and affected by a variety of federal and state laws, regulations and policies.
» More Articles for ABC

Headlines

Articles On GuruFocus.com
A Short-Term Problem Creates Long-Term Opportunity in Lannett Company Jan 12 2016 
Walgreens Buys Rite Aid to Avoid Loose Market Nov 04 2015 
The Case for Investing in AmerisourceBergen Aug 13 2015 
Why Hedge Funds Are Betting On AmerisourceBergen Apr 10 2015 
Apple TV And Online TV Service Will Be Released This Year Mar 24 2015 
Weekly 52-Week Highs Highlight: IR, ORAN, EL, ABC Feb 14 2015 
Must Buy From Media And Entertainment Sector Feb 03 2015 
Walgreen Is Well-Equipped For A Stronger Comeback Feb 02 2015 
Cardinal Health, Inc. (CAH) Dividend Stock Analysis Dec 17 2014 
AmerisourceBergen a Key Player in the Pharma Industry Dec 10 2014 

More From Other Websites
[$$] McKesson Posts Higher Profit on 4% Revenue Increase May 04 2016
The Zacks Analyst Blog Highlights: Zoetis, McKesson, Merck, Endo International and AmerisourceBergen May 04 2016
Drug Stocks Reporting Mid-Week: MRK, ABC, ENDP & More May 03 2016
AmerisourceBergen (ABC) Q2 Earnings: Stock to Surprise? May 02 2016
Barron's 500: America's Top Companies May 01 2016
[$$] The Barron's 500: AmerisourceBergen Ranks No. 1 Apr 29 2016
This Weekend's Barron's: America's Top 500 Companies ~ ISIS Will Soon Fall ~ Three Attractive... Apr 29 2016
AmerisourceBergen Corp. breached its 50 day moving average in a Bearish Manner : ABC-US : April 29,... Apr 29 2016
AMERISOURCEBERGEN CORP Files SEC form 8-K, Change in Directors or Principal Officers, Financial... Apr 22 2016
AmerisourceBergen Executive Vice President of Retail Strategy and President of Good Neighbor... Apr 22 2016
AmerisourceBergen Executive Vice President of Retail Strategy and President of Good Neighbor... Apr 22 2016
AmerisourceBergen Announces Date and Time for Second Quarter Fiscal 2016 Earnings Release Apr 19 2016
AmerisourceBergen Announces Date and Time for Second Quarter Fiscal 2016 Earnings Release Apr 19 2016
Coverage initiated on AmerisourceBergen by Avondale Apr 19 2016
PharMerica ordered to pay $48.5 million in drug deal gone wrong Apr 13 2016
How to Create a Great Workplace in Health Care Apr 12 2016
Lash Group celebrates move to new 1,200-employee Fort Mill HQ (PHOTOS) Apr 11 2016
How Do WBA’s Valuations Compare to Peers? Apr 08 2016
AmerisourceBergen Corp. – Value Analysis (NYSE:ABC) : April 7, 2016 Apr 07 2016
Recommendation to the Management Board regarding profit distribution and dividend payment along with... Apr 07 2016
AmerisourceBergen Corp. breached its 50 day moving average in a Bearish Manner : ABC-US : April 6,... Apr 06 2016
Walgreens tops 2Q profit expectations, narrows 2016 forecast Apr 05 2016
Walgreens tops 2Q profit expectations, narrows 2016 forecast Apr 05 2016
PharMerica Provides Update on AmerisourceBergen Litigation Apr 04 2016
How Were WBA’s Margins and Profitability in 1Q16? Apr 01 2016
Walgreens Buys AmerisourceBergen Shares per Warrants Mar 21 2016
$1.17B stock buy: Walgreens Boots Alliance increases stake in AmerisourceBergen Mar 18 2016
Walgreens spends nearly $1.2 B on AmerisourceBergen shares Mar 18 2016
MWI Animal Health Acquires United Kingdom’s Largest Veterinary GPO, St. Francis Group Feb 16 2016
Tax gain lifts wholesaler AmerisourceBergen to 1Q profit Feb 04 2016
Notifiaction under Article 160 of the Act on Trading in Financial Instruments Jan 19 2016
Launch of New Product Range and Distribution Agreement Jan 14 2016
AmerisourceBergen Announces Upcoming Investor Events Jan 08 2016
Instigation of liquidation proceedings with respect to ABC Data Germany GmbH Dec 29 2015
ABC Data joins the group of the strongest business brands! Dec 02 2015
AmerisourceBergen Announces Changes to Its Board of Directors and Adoption of Proxy Access Nov 18 2015
ABC Data’s profit grows by 59% Nov 17 2015
Correction of the consolidated quarterly report for Q3 2015 Nov 17 2015
Forecast of the ABC Data S.A. Capital Group for 2015 Nov 17 2015
AmerisourceBergen Completes Acquisition of PharMEDium Healthcare Holdings, Inc. Nov 06 2015
AmerisourceBergen Increases Dividend 17 Percent Nov 06 2015
Turkey's Fibabanka joins race for HSBC's Turkish unit -sources Nov 04 2015
The strong ABC Data team has new directors Nov 02 2015
AmerisourceBergen Reports Fourth Quarter and Fiscal Year 2015 Results Oct 29 2015
AmerisourceBergen misses 4Q profit forecasts Oct 29 2015
List of shareholders holding at least 5% of votes at the EGM of the Company on 21 October 2015 Oct 26 2015
Resolutions adopted on Extraordinary General Meeting of ABC Data S.A. on 21 October 2015 Oct 26 2015
AmerisourceBergen to Acquire PharMEDium Healthcare Holdings, Inc. Oct 06 2015
AmerisourceBergen beats Street 3Q forecasts Jul 23 2015
HSBC to agree sale of Turkish unit to ING for around $750 mln -sources Jul 22 2015
Qatar's QNB and Bahrain's ABC looking at Turkey's Finansbank - sources Jul 02 2015
HSBC to shed 50,000 jobs in quest for higher payouts Jun 09 2015
HSBC set to cut thousands of jobs globally - Sky News Jun 02 2015
HSBC set to cut thousands of jobs globally - Sky News Jun 01 2015
HSBC set to cut thousands of jobs globally - Sky News Jun 01 2015
ING and BNP Paribas among bidders for HSBC Turkey -source May 29 2015
ING, Bahrain's ABC, BNP Paribas submit initial bids for HSBC Turkey -source May 29 2015
Saudi's Algosaibi to present improved offer to creditors June 2 May 18 2015
AmerisourceBergen reports 2Q loss Apr 30 2015
Amerisource wows with US$9bn book for US$1bn deal Feb 17 2015
AmerisourceBergen reports 1Q loss Jan 28 2015
AmerisourceBergen expands into animal health with $2.5B deal Jan 12 2015
AmerisourceBergen to spend $2.5B on MWI Veterinary Supply Jan 12 2015
AmerisourceBergen beats Street 4Q forecasts Oct 30 2014
MOVES- Deutsche Asset & Wealth Management, Barclays, Credit Suisse Jul 14 2014

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK